Clinical Trial - Trial ChiCTR2200057754
Access comprehensive clinical trial information for ChiCTR2200057754 through Pure Global AI's free database. This Phase 4 trial is sponsored by BEIJING TIANTAN HOSPITAL,CAPTIAL MEDICAL UNIVERSITY and is currently Not yet recruiting. The study focuses on lung cancer.
This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to Chinese Clinical Trial Registry data, helping medical device and pharmaceutical companies navigate clinical research efficiently.
Free Database
Powered by Pure Global AI
840K+ Trials
ChiCTR2200057754
Phase 4
Not yet recruiting
Trial Details
Chinese Clinical Trial Registry • ChiCTR2200057754
View on Chinese Clinical Trial Registry
Untitled Trial
A real-world multicenter retrospective prospective clinical study of the efficacy and safety of Ensartinib capsules in patients with advanced ALK-positive non-small cell lung cancer
Study Focus
Sponsor & Location
BEIJING TIANTAN HOSPITAL,CAPTIAL MEDICAL UNIVERSITY
self-funds
China
Timeline & Enrollment
Phase 4
N/A
Oct 01, 2023
ICD-10 Classifications
Carcinoma in situ: Bronchus and lung
Secondary malignant neoplasm of lung
Malignant neoplasm of bronchus and lung
Malignant neoplasm: Bronchus or lung, unspecified
Malignant neoplasm: Overlapping lesion of bronchus and lung
Data Source
Chinese Clinical Trial Registry
ChiCTR2200057754
Non-Device Trial